Insider Transactions in Q2 2023 at Insmed Inc (INSM)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 13
2023
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
8,981
-5.6%
|
$170,639
$19.32 P/Share
|
|
Jun 13
2023
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,868
-7.72%
|
$168,492
$19.27 P/Share
|
|
May 25
2023
|
John Drayton Wise Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,366
-3.17%
|
$60,588
$18.95 P/Share
|
|
May 17
2023
|
John Drayton Wise Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,913
-1.77%
|
$34,434
$18.17 P/Share
|
|
May 17
2023
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
7,099
-2.04%
|
$127,782
$18.12 P/Share
|
|
May 17
2023
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,972
-2.07%
|
$35,496
$18.16 P/Share
|
|
May 17
2023
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,263
-1.61%
|
$22,734
$18.18 P/Share
|
|
May 17
2023
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,448
-1.5%
|
$44,064
$18.12 P/Share
|
|
May 16
2023
|
John Drayton Wise Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
381
-0.35%
|
$6,858
$18.44 P/Share
|
|
May 16
2023
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,610
-1.35%
|
$28,980
$18.47 P/Share
|
|
May 16
2023
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,718
-1.47%
|
$30,924
$18.43 P/Share
|
|
May 16
2023
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
3,714
-1.05%
|
$66,852
$18.41 P/Share
|
|
May 16
2023
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,217
-1.26%
|
$21,906
$18.45 P/Share
|
|
May 16
2023
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
475
-0.6%
|
$8,550
$18.43 P/Share
|
|
May 16
2023
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,521
-0.93%
|
$27,378
$18.39 P/Share
|
|
May 15
2023
|
John Drayton Wise Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
593
-0.54%
|
$11,267
$19.29 P/Share
|
|
May 15
2023
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,210
-1.82%
|
$41,990
$19.3 P/Share
|
|
May 15
2023
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,576
-2.16%
|
$48,944
$19.28 P/Share
|
|
May 15
2023
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
6,048
-1.69%
|
$114,912
$19.23 P/Share
|
|
May 15
2023
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,830
-1.86%
|
$34,770
$19.22 P/Share
|
|
May 15
2023
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,897
-2.35%
|
$36,043
$19.24 P/Share
|
|
May 15
2023
|
Melvin Md Sharoky Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+50.0%
|
$190,000
$19.29 P/Share
|
|
May 15
2023
|
Melvin Md Sharoky Director |
BUY
Open market or private purchase
|
Direct |
10,000
+3.24%
|
$190,000
$19.29 P/Share
|
|
May 15
2023
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,847
-1.7%
|
$54,093
$19.27 P/Share
|
|
May 12
2023
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
233,924
+37.3%
|
$2,807,088
$12.44 P/Share
|
|
May 11
2023
|
Clarissa Desjardins Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,192
+21.28%
|
-
|
|
May 11
2023
|
Leo Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,192
+10.58%
|
-
|
|
May 11
2023
|
David W J Mcgirr Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,192
+13.33%
|
-
|
|
May 11
2023
|
Carol Schafer Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,192
+22.63%
|
-
|
|
May 11
2023
|
Melvin Md Sharoky Director |
SELL
Bona fide gift
|
Direct |
1,800
-0.62%
|
-
|
|
May 11
2023
|
Melvin Md Sharoky Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,192
+4.35%
|
-
|
|
May 11
2023
|
Alfred Altomari Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,192
+18.97%
|
-
|
|
May 11
2023
|
Elizabeth M Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,192
+19.2%
|
-
|
|
May 11
2023
|
David R Brennan Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,192
+10.82%
|
-
|
|
May 11
2023
|
William Lewis Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
93,139
+20.64%
|
-
|
|
May 11
2023
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,385
+21.12%
|
-
|
|
May 11
2023
|
Michael Alexander Smith Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,385
+24.64%
|
-
|
|
May 11
2023
|
John Drayton Wise Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,662
+22.52%
|
-
|
|
May 11
2023
|
Sara Bonstein Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,408
+20.14%
|
-
|
|
May 11
2023
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46,437
+17.15%
|
-
|
|
May 11
2023
|
Roger Adsett Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,662
+15.93%
|
-
|